Literature DB >> 1855128

Facilitation of amphetamine-induced hypothermia in mice by GABA agonists and CCK-8.

G Boschi1, N Launay, R Rips.   

Abstract

1. Amphetamine-induced hypothermia in mice is facilitated by dopaminergic stimulation and 5-hydroxytryptaminergic inhibition. The present study was designed to investigate: (a) the involvement of other neuronal systems, such as the gamma-aminobutyric acid (GABA), the opioid and the cholecystokinin (CCK-8) systems; (b) the possible contribution of hydroxylated metabolites of amphetamine to the hypothermia; (c) the capacity of dopamine itself to induce hypothermia and its mechanisms, in order to clarify the resistance of amphetamine-induced hypothermia to certain neuroleptics. 2. Pretreatment with the GABA antagonists, bicuculline and picrotoxin, did not inhibit amphetamine-induced hypothermia. The GABAB agonist, baclofen (2.5 mg kg-1, i.p.) potentiated this hypothermia, whereas the GABAA agonist, muscimol, did not. gamma-Butyrolactone (GBL) (40 mg kg-1, i.p.) and the neuropeptide CCK-8 (0.04 mg kg-1, i.p.) also induced potentiation. The opioid antagonist, naloxone, was without effect. 3. Dopamine itself (3, 9, 16 and 27 micrograms, i.c.v.) induced less hypothermia than the same doses of amphetamine. Sulpiride did not block dopamine-induced hypothermia, but pimozide (4 mg kg-1, i.p.), cis(z)flupentixol (0.25 mg kg-1, i.p.) and haloperidol (5 micrograms, i.c.v.) did. The direct dopamine receptor agonist, apomorphine, did not alter the hypothermia. Neither the 5-hydroxytryptamine (5-HT) receptor blocker, cyproheptadine, nor the inhibitor of 5-HT synthesis, p-chlorophenylalanine (PCPA), modified dopamine-induced hypothermia. Fluoxetine, an inhibitor of 5-HT reuptake, had no effect, whereas quipazine (6 mg kg-1, i.p.), a 5-HT agonist, totally prevented the hypothermia. Hypothermia was unaffected by pretreatment with CCK-8. 4. These data indicate that the hypothermia induced by amphetamine involves not only dopaminergic and 5-hydroxytryptaminergic systems which are functionally antagonistic, but is also facilitated by direct or indirect GABA and CCK-8 receptor stimulation. This facilitation could result, in part, from modulation of dopaminergic neurotransmission. This may explain the apparent resistance of amphetamineinduced hypothermia to some neuroleptics, while dopamine-induced hypothermia is not resistant. The possible action of hydroxylated metabolites of amphetamine may also help to explain these differences.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1855128      PMCID: PMC1917989          DOI: 10.1111/j.1476-5381.1991.tb12288.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Regional gamma-aminobutyric acid levels in rat brain determined after microwave fixation.

Authors:  G J Balcom; R H Lenox; J L Meyerhoff
Journal:  J Neurochem       Date:  1975-04       Impact factor: 5.372

2.  Dopamine-GABA interactions: evidence that GABA transmits, modulates and mediates dopaminergic functions in the basal ganglia and the limbic system.

Authors:  J Scheel-Krüger
Journal:  Acta Neurol Scand Suppl       Date:  1986

3.  Distinct properties of cholecystokinin-8 and mixed dopamine-cholecystokinin-8 neurons innervating the nucleus accumbens.

Authors:  J M Studler; M Reibaud; G Tramu; G Blanc; J Glowinski; J P Tassin
Journal:  Ann N Y Acad Sci       Date:  1985       Impact factor: 5.691

4.  A subpopulation of mesencephalic dopamine neurons projecting to limbic areas contains a cholecystokinin-like peptide: evidence from immunohistochemistry combined with retrograde tracing.

Authors:  T Hökfelt; L Skirboll; J F Rehfeld; M Goldstein; K Markey; O Dann
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

5.  Forebrain sites for the hypothermic effect of dexamphetamine in mice.

Authors:  G Boschi; R Rips
Journal:  Neurosci Lett       Date:  1982-08-16       Impact factor: 3.046

6.  The distribution and origin of glutamate decarboxylase and choline acetyltransferase in ventral pallidum and other basal forebrain regions.

Authors:  I Walaas; F Fonnum
Journal:  Brain Res       Date:  1979-11-16       Impact factor: 3.252

7.  [3H](-)Baclofen: an improved ligand for GABAB sites.

Authors:  N G Bowery; D R Hill; A L Hudson
Journal:  Neuropharmacology       Date:  1985-03       Impact factor: 5.250

8.  Neurochemical effects of amphetamine metabolites on central dopaminergic and serotonergic systems.

Authors:  L A Matsuda; G R Hanson; J W Gibb
Journal:  J Pharmacol Exp Ther       Date:  1989-12       Impact factor: 4.030

9.  Inhibition by GABA, baclofen and gabapentin of dopamine release from rabbit caudate nucleus: are there common or different sites of action?

Authors:  W Reimann
Journal:  Eur J Pharmacol       Date:  1983-10-28       Impact factor: 4.432

10.  Differential effects of neuroleptic and serotonergic drugs on amphetamine-induced hypothermia in mice.

Authors:  G Boschi; N Launay
Journal:  Neuropharmacology       Date:  1985-02       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.